NUSIRT SCIENCES INC.

Profile

Company Names

NUSIRT SCIENCES INC.

Addresses

3835 CLEGHORN AVENUE SUITE 200, NASHVILLE, TN 37215

3835 CLEGHORN AVENUE, SUITE 200, NASHVILLE, TN 37215

Phone Numbers

615-656-7898

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$8,070,068.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2016-11-22 
$1,999,997.00 
$1,999,997.00 
$0.00 
Equity 
2
2015-09-30 
$4,000,071.00 
$8,000,142.00 
$4,000,071.00 
Equity 
1
2015-05-07 
$2,070,000.00 
$6,000,000.00 
$3,930,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VAUGHN 
 
BRYSON 
DIRECTOR
NUSIRT SCIENCES INC.   |  APPELLO PHARMACEUTICALS, INC.
BARBARA 
 
CANNON 
EXECUTIVE OFFICER
NUSIRT SCIENCES INC.   |  REIMAGINE CARE, INC.
JOSEPH 
C. 
COOK, JR. 
EXECUTIVE OFFICER, DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  CORCEPT THERAPEUTICS INC   |  MGC VENTURE PARTNERS 2013, L.P.   |  NUSIRT SCIENCES INC.   |  SKYLINE VET PHARMA, INC.   |  CASTLE BIOSCIENCES INC   |  MGC VENTURE PARTNERS 2018, L.P.   |  MGC VENTURE PARTNERS QP 2018, L.P.
BRIAN 
 
LADEN 
DIRECTOR
GOBA, LLC   |  VENX, LLC   |  DEVICE INNOVATION GROUP, LLC   |  CEREBROTECH MEDICAL SYSTEMS, INC.   |  NUSIRT SCIENCES INC.   |  APPELLO PHARMACEUTICALS, INC.   |  GENOMONCOLOGY, LLC   |  ANGELEYE HEALTH, INC.
ERIC 
 
SATZ 
DIRECTOR
PROPLAYERCONNECT.COM INC   |  KRUSH, INC.   |  NUMETA SCIENCES, INC.   |  CYBER PHYSICAL SYSTEMS, INC.   |  STREAMWEAVER, INC.   |  OVERDOG, INC.   |  NUSIRT SCIENCES INC.   |  ALTO SOLUTIONS, INC.   |  ALTO CAPITAL FUND I, LLC-KEARNY JACKSON FUND I
MICHAEL 
 
ZEMEL 
DIRECTOR, EXECUTIVE OFFICER
NUMETA SCIENCES, INC.   |  NUSIRT SCIENCES INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-12-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-22 
2015-10-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
2015-05-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
N/A
NONE
N/A
NONE